TATSIS OURANIA 1789815 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-14 | 2023-08-10 | 2023-08-10 | 4 | Tatsis Ourania | EVP, CHIEF REG. & QUALITY OFF. | dsp | 5750.0 | 10.11 | 0.22 | 345.79 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 51137.0 | 258.09 (VRTX) |
| 2023-08-25 | 2023-08-23 | 2023-08-23 | 4 | Tatsis Ourania | EVP, CHIEF REG. & QUALITY OFF. | dsp | 2500.0 | 4.89 | 0.1 | 355.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 48637.0 | 258.09 (VRTX) |
| 2024-02-08 | 2024-02-06 | 2024-02-06 to 2024-02-07 | 4 | Tatsis Ourania | EVP, CHIEF REG. & QUALITY OFF. | acq | 21956.0 | 31.1 | 0.85 | 0.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code A | 70593.0
|
257.68 (VRTX) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 to 2024-02-12 | 4 | Tatsis Ourania | EVP, CHIEF REG. & QUALITY OFF. | dsp | 2414.0 | 3.42 | 0.09 | 422.41 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 68179.0
|
257.68 (VRTX) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 to 2024-02-20 | 4 | Tatsis Ourania | EVP, CHIEF REG. & QUALITY OFF. | dsp | 8352.0 | 12.25 | 0.32 | 422.44 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 59827.0
|
258.31 (VRTX) |
| 2024-02-23 | 2024-02-21 | 2024-02-21 | 4 | Tatsis Ourania | EVP, CHIEF REG. & QUALITY OFF. | dsp | 360.0 | 0.6 | 0.01 | 421.77 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 59467.0 | 258.31 (VRTX) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 to 2024-02-26 | 4 | Tatsis Ourania | EVP, CHIEF REG. & QUALITY OFF. | dsp | 3663.0 | 6.16 | 0.14 | 431.2 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 55804.0
|
258.31 (VRTX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)